Paul Goddard is Director at ONYX PHARMACEUTICALS INC (ONXX). They have made 5 open-market trades across 2 companies since 2006, most recently 2013-10-01.
CIK 0001227124
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2006, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONXX | SELL · 10b5-1 | 2013-07-01 | 2013-07-02 | $132.22 | $793K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-05-08 | 2013-05-08 | $95.00 | $95K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-05-01 | 2013-05-03 | $93.02 | $465K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-04-10 | 2013-04-11 | $95.00 | $190K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-03-08 | 2013-03-11 | $85.00 | $85K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-03-01 | 2013-03-05 | $74.35 | $297K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-01-09 | 2013-01-11 | $83.20 | $416K | N/A | N/A | N/A |
| ONXX | SELL | 2012-08-30 | 2012-08-31 | $71.40 | $357K | N/A | N/A | N/A |
| ONXX | SELL | 2008-08-18 | 2008-08-19 | $44.77 | $291K | N/A | N/A | N/A |
| ONXX | SELL | 2008-08-12 | 2008-08-13 | $39.93 | $200K | N/A | N/A | N/A |
| ONXX | SELL | 2007-08-15 | 2007-08-16 | $32.68 | $376K | N/A | N/A | N/A |
| APPA | BUY | 2006-06-29 | 2006-06-29 | $1.50 | $15K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.